{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:36:39Z","timestamp":1793039799136,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10810"],"award-info":[{"award-number":["17K10810"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.lfs.2019.117110","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T02:19:51Z","timestamp":1574907591000},"page":"117110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Fluvastatin is effective against thymic carcinoma"],"prefix":"10.1016","volume":"240","author":[{"given":"Keitaro","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Morito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Chida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117110_bb0005","series-title":"General Thoracic Surgery","first-page":"2323","article-title":"Thymic tumors","author":"Shields","year":"2009"},{"key":"10.1016\/j.lfs.2019.117110_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2019.117110_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14797\/mdcj-15-1-23","article-title":"Statins: then and now","volume":"15","author":"Toth","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"10.1016\/j.lfs.2019.117110_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2019.117110_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1040-8428(96)00193-X","article-title":"HMG-CoA reductase inhibitors: role in normal and malignant cells","volume":"22","author":"Larsson","year":"1996","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lfs.2019.117110_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.lfs.2019.117110_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4149\/gpb_2017045","article-title":"The role of statins as therapeutic agents in cancer","volume":"36","author":"Sopkov\u00e1","year":"2017","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.lfs.2019.117110_bb0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ijc.30526","article-title":"Effects of statins on cancer mortality and progression: a systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals","volume":"140","author":"Mei","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2019.117110_bb0045","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancerrelated mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.117110_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1200\/JCO.2016.70.3116","article-title":"Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study","volume":"35","author":"Borgquist","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2019.117110_bb0055","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S1470-2045(14)70119-6","article-title":"Statins and breast cancer prognosis: evidence and opportunities","volume":"15","author":"Ahern","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2019.117110_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.oraloncology.2019.01.019","article-title":"Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer","volume":"90","author":"Gupta","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.lfs.2019.117110_bb0065","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/cam4.2151","article-title":"Statin uses and mortality in colorectal cancer patients: an updated systematic review and meta-analysis","volume":"8","author":"Li","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2019.117110_bb0070","first-page":"385","article-title":"Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study","volume":"30","author":"Lacroix","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.lfs.2019.117110_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MPA.0000000000001226","article-title":"Statin use and risk of pancreatic cancer: an updated meta-analysis of 26 studies","volume":"48","author":"Zhang","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.lfs.2019.117110_bb0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1074248414529622","article-title":"Addressing statin adverse effects in the clinic: the 5 Ms","volume":"19","author":"Katz","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2019.117110_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth","volume":"21","author":"Brown","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2019.117110_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2019.117110_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0092-8674(89)90054-8","article-title":"All ras proteins are polyisoprenylated but only some are palmitoylated","volume":"57","author":"Hancock","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117110_bb0100","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1073\/pnas.86.21.8323","article-title":"p21ras is modified by a farnesyl isoprenoid","volume":"86","author":"Casey","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2019.117110_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2019.117110_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2019.117110_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2011.11.145","article-title":"MEK1\/2 dual-specificity protein kinases: structure and regulation","volume":"417","author":"Roskoski","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.117110_bb0120","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","article-title":"Breast cancer growth prevention by statins","volume":"66","author":"Campbell","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117110_bb0125","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-14-3368","article-title":"Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models","volume":"21","author":"Kobayashi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.117110_bb0130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/ijc.27456","article-title":"Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3\/AKT signaling in p48Cre\/+ LSL-KrasG12D\/+ mice","volume":"131","author":"Mohammed","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2019.117110_bb0135","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/JTO.0b013e3181f1cab3","article-title":"Evaluation of Kras gene mutation and copy number in thymic carcinomas and thymomas","volume":"5","author":"Sasaki","year":"2010","journal-title":"J. Thorac. Oncol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:42:03Z","timestamp":1793036523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519310379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"alternative-id":["S0024320519310379"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117110","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluvastatin is effective against thymic carcinoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117110"}}